Learn / ZYME
NASDAQ: ZYME
Zymeworks (ZYME) stock, explained like you're 5
Zymeworks trades on the Nasdaq under the ticker ZYME. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.8 billion dollars.
- Ticker
- ZYME
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 1.8 billion dollars
Is Zymeworks a small, medium or large cap company?
No. Zymeworks is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.8 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Zymeworks makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves ZYME stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Zymeworks Inc. (ZYME) Stock Price, News, Quote & History (Yahoo! Finance Canada)
- JAZZ, ONC, ZYME Stocks In Focus After FDA Approves Gastroesophageal Cancer Therapy (Stocktwits)
- Assenagon Asset Management S.A. Buys 256,042 Shares of Zymeworks Inc. $ZYME (MarketBeat)
- Zymeworks Announces Third Quarter 2026 Financial Results Date and Upcoming Investor Conference Participation (Quiver Quantitative)
- Zymeworks schedules November 9 results: Truist targets Zymeworks stock at USD 34.00 (ad-hoc-news.de)
Follow ZYME in your daily brief
Each trading day at 5 PM ET we post what happened to Zymeworks and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow ZYME
Questions about Zymeworks stock
What does Zymeworks do?
Zymeworks trades on the Nasdaq under the ticker ZYME. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.8 billion dollars.
What is the ticker symbol for Zymeworks?
Zymeworks trades under the ticker ZYME on the Nasdaq.
What is Zymeworks's market cap?
Zymeworks is a small cap stock with a market cap of about 1.8 billion dollars.
How does Zymeworks make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves ZYME stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow ZYME stock every day?
Add ZYME to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.